Jiayi Zhou, OD, PHD | |
31 Mall Rd, Department Of Ophthalmology, Burlington, MA 01803 | |
(781) 744-8555 | |
(781) 744-2540 |
Full Name | Jiayi Zhou |
---|---|
Gender | Male |
Speciality | Optometry |
Experience | 8 Years |
Location | 31 Mall Rd, Burlington, Massachusetts |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1396285748 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
152W00000X | Optometrist | 0940 (New Hampshire) | Secondary |
152W00000X | Optometrist | 5200 (Massachusetts) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Lahey Hospital & Medical Center, Burlington | Burlington, MA | Hospital |
Provider Name | Lahey Clinic Inc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1538194980 PECOS PAC ID: 2264336528 Enrollment ID: O20031120000097 |
News Archive
TherapeuticsMD, Inc., a women's healthcare company and parent company of vitaMedMD, announced today the launch of vitaMedMD's newest prescription prenatal multivitamin, vitaPearl, adding to its successful prenatal line consisting of vitaMedMD One Rx, vitaMedMD Plus Rx, and vitaMedMD RediChew™ Rx.
It all happened by chance. It was a hot summer day nine years ago. Inside the laboratory, the team was working on cancer research. On the lab bench, various medications were being tested on cancer cells.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that the Gynecologic Oncology Group (GOG) will initiate a Phase 2 clinical trial of elesclomol in combination with paclitaxel for the treatment of persistent or recurrent ovarian, fallopian tube or primary peritoneal cancer.
The human immunodeficiency virus (HIV) can contain dozens of different mutations, called polymorphisms. In a recent study an international team of researchers, including MU scientists, found that one of those mutations, called 172K, made certain forms of the virus more susceptible to treatment. Soon, doctors will be able to use this knowledge to improve the drug regiment they prescribe to HIV-infected individuals.
› Verified 3 days ago
Provider Name | Lahey Clinic Inc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1063447316 PECOS PAC ID: 2264336528 Enrollment ID: O20040629001269 |
News Archive
TherapeuticsMD, Inc., a women's healthcare company and parent company of vitaMedMD, announced today the launch of vitaMedMD's newest prescription prenatal multivitamin, vitaPearl, adding to its successful prenatal line consisting of vitaMedMD One Rx, vitaMedMD Plus Rx, and vitaMedMD RediChew™ Rx.
It all happened by chance. It was a hot summer day nine years ago. Inside the laboratory, the team was working on cancer research. On the lab bench, various medications were being tested on cancer cells.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that the Gynecologic Oncology Group (GOG) will initiate a Phase 2 clinical trial of elesclomol in combination with paclitaxel for the treatment of persistent or recurrent ovarian, fallopian tube or primary peritoneal cancer.
The human immunodeficiency virus (HIV) can contain dozens of different mutations, called polymorphisms. In a recent study an international team of researchers, including MU scientists, found that one of those mutations, called 172K, made certain forms of the virus more susceptible to treatment. Soon, doctors will be able to use this knowledge to improve the drug regiment they prescribe to HIV-infected individuals.
› Verified 3 days ago
Provider Name | Jz Eye Care, Llc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1316423874 PECOS PAC ID: 1052669397 Enrollment ID: O20180802003424 |
News Archive
TherapeuticsMD, Inc., a women's healthcare company and parent company of vitaMedMD, announced today the launch of vitaMedMD's newest prescription prenatal multivitamin, vitaPearl, adding to its successful prenatal line consisting of vitaMedMD One Rx, vitaMedMD Plus Rx, and vitaMedMD RediChew™ Rx.
It all happened by chance. It was a hot summer day nine years ago. Inside the laboratory, the team was working on cancer research. On the lab bench, various medications were being tested on cancer cells.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that the Gynecologic Oncology Group (GOG) will initiate a Phase 2 clinical trial of elesclomol in combination with paclitaxel for the treatment of persistent or recurrent ovarian, fallopian tube or primary peritoneal cancer.
The human immunodeficiency virus (HIV) can contain dozens of different mutations, called polymorphisms. In a recent study an international team of researchers, including MU scientists, found that one of those mutations, called 172K, made certain forms of the virus more susceptible to treatment. Soon, doctors will be able to use this knowledge to improve the drug regiment they prescribe to HIV-infected individuals.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Jiayi Zhou, OD, PHD 31 Mall Rd, Department Of Ophthalmology, Burlington, MA 01803-4138 Ph: (781) 744-8555 | Jiayi Zhou, OD, PHD 31 Mall Rd, Department Of Ophthalmology, Burlington, MA 01803 Ph: (781) 744-8555 |
News Archive
TherapeuticsMD, Inc., a women's healthcare company and parent company of vitaMedMD, announced today the launch of vitaMedMD's newest prescription prenatal multivitamin, vitaPearl, adding to its successful prenatal line consisting of vitaMedMD One Rx, vitaMedMD Plus Rx, and vitaMedMD RediChew™ Rx.
It all happened by chance. It was a hot summer day nine years ago. Inside the laboratory, the team was working on cancer research. On the lab bench, various medications were being tested on cancer cells.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that the Gynecologic Oncology Group (GOG) will initiate a Phase 2 clinical trial of elesclomol in combination with paclitaxel for the treatment of persistent or recurrent ovarian, fallopian tube or primary peritoneal cancer.
The human immunodeficiency virus (HIV) can contain dozens of different mutations, called polymorphisms. In a recent study an international team of researchers, including MU scientists, found that one of those mutations, called 172K, made certain forms of the virus more susceptible to treatment. Soon, doctors will be able to use this knowledge to improve the drug regiment they prescribe to HIV-infected individuals.
› Verified 3 days ago
Dr. Thomas R Corwin, OD,PHD,FAAO Optometrist Medicare: Not Enrolled in Medicare Practice Location: 101 Middlesex Tpke, Burlington, MA 01803 Phone: 781-270-9800 | |
Dr. Tara L. Sullivan, O.d. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 74 Burlington Mall Road, Burlington, MA 01803 Phone: 781-272-5620 | |
Dr. Bradley M Howerter, OD Optometrist Medicare: Medicare Enrolled Practice Location: 31 Burlington Mall Rd, Burlington, MA 01803 Phone: 781-744-8555 | |
Burlington Eye Group, Inc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 74 Burlington Mall Road, Burlington, MA 01803 Phone: 781-272-5620 | |
Robert Johnson, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 172 Cambridge Street, Burlington, MA 01803 Phone: 781-272-4944 Fax: 781-272-8756 | |
Catherine A Kennedy, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 83 Cambridge St Ste 1d, Burlington, MA 01803 Phone: 781-272-2187 Fax: 781-229-0869 | |
Nicole Frances Theiss, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 74 Burlington Mall Rd, Burlington, MA 01803 Phone: 781-272-5620 |